Growth Metrics

Innoviva (INVA) EBIT (2016 - 2025)

Innoviva (INVA) has disclosed EBIT for 16 consecutive years, with $124.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBIT rose 188.54% year-over-year to $124.8 million, compared with a TTM value of $154.8 million through Sep 2025, down 3.12%, and an annual FY2025 reading of $163.7 million, down 1.87% over the prior year.
  • EBIT was $124.8 million for Q3 2025 at Innoviva, up from $48.8 million in the prior quarter.
  • Across five years, EBIT topped out at $484.7 million in Q3 2022 and bottomed at -$65.2 million in Q2 2023.
  • Average EBIT over 5 years is $71.3 million, with a median of $25.8 million recorded in 2024.
  • The sharpest move saw EBIT soared 1530.16% in 2022, then plummeted 171.23% in 2023.
  • Year by year, EBIT stood at -$6.0 million in 2021, then tumbled by 70.77% to -$10.3 million in 2022, then soared by 36.31% to -$6.6 million in 2023, then tumbled by 60.22% to -$10.5 million in 2024, then skyrocketed by 1283.77% to $124.8 million in 2025.
  • Business Quant data shows EBIT for INVA at $124.8 million in Q3 2025, $48.8 million in Q2 2025, and -$8.2 million in Q1 2025.